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Extent of thrombus evaluated in patients with
recurrent and first deep vein thrombosis
Astrid M. Fink, MD, Wolfgang Mayer, MD, and Andreas Steiner, MD, Vienna, Austria
Objectives: The objective of this retrospective study was to document the extent of thrombus in patients with recurrent and
first deep vein thrombosis (DVT).
Patients and methods: A total of 864 patients with DVT of the leg were enrolled in the study. They were divided into two
groups: patients with recurrent DVT (n  233) of the leg, and patients with first DVT of the leg (n  631). In both
groups the extent of the thrombus was evaluated by duplex scanning, contrast venography, or magnetic resonance
imaging. Thrombus involving veins distal to the popliteal vein was classified as distal DVT, whereas involvement of the
popliteal vein and proximal was classified as proximal DVT.
Results: We could demonstrate that involvement of proximal segments (CEAP anatomic classification 1-9) occurred
significantly more often in patients with recurrent DVT than in patients with the first DVT (P < .001). The incidence of
pulmonary embolism (PE) and the clinical symptoms of PE were equally distributed between patients with recurrent
DVT and those with first DVT (P > .05). Only one patient died as a consequence of PE in our patient sample.
Conclusions: In our experience, patients with recurrent DVT have a higher frequency of proximal DVT. Nevertheless, the
incidence of PE is similar in patients with recurrent and those with first DVT. (J Vasc Surg 2002;36:357-60.)
Deep vein thrombosis (DVT) of the lower extremity is
a serious disorder with an estimated yearly incidence rang-
ing from 0.5 to 1.6 per 1000 individuals.1-3 The recurrence
rate after first DVT is high.2-7 Although numerous studies
have been undertaken to determine the risk factors for
recurrent DVT,5-9 information about the clinical features
remain scarce. It is commonly believed that there is an
increased risk of pulmonary embolism (PE) associated with
proximal DVT when compared with distal DVT of the
leg.10-15 Therefore, the question arises whether patients
with recurrent DVT of the leg might have a different
distribution of proximal and distal DVT of the leg than
patients with first DVT. To our knowledge, there are no
previous reports in which the distribution of proximal and
distal DVT has been studied in patients with recurrent
DVT and in concurrent patients with the first episode of
DVT.
The present study was undertaken to investigate the
incidence of proximal (level of popliteal veins and proximal)
and distal (distal to the popliteal veins) DVT of the leg in
patients with recurrent DVT compared to those with first
DVT. In addition, the frequency of PE and the early clinical
outcome was evaluated in these two groups of patients.
PATIENTS AND METHODS
The case material in this report is derived from our
database of DVT, which includes information for all con-
secutive patients with acute, symptomatic DVT who were
admitted to our department from January 1996 to Decem-
ber 2000. On the basis of institutional tradition, our De-
partment of Dermatology has a longstanding interest in
phlebologic diseases.
From 1996 to 2000, 905 consecutive patients with
DVT that was documented by duplex scanning or contrast
phlebography were hospitalized and treated by members of
our department. Contrast phlebography (n  9; Fig 1) or
magnetic resonance imaging (MRI, n  2; Fig 2) was
performed whenever duplex scanning was not sufficient to
establish the diagnosis. The diagnosis of recurrent DVT
remained unclear in 41 of the 905 patients. These patients
were excluded from the study because their previous his-
tory of DVT was based on recollection alone and could not
be verified. The remaining 864 patients were enrolled in
the study. These patients were divided into the following
two groups: (1) patients with their first episode of DVT
(n  631), and (2) patients with one or more episodes of
DVT, which collectively were considered to represent re-
current DVT (n  233). Patients were classified as having
recurrent DVT only on the basis of a well-documented
previous history.
The series included 465 women and 399 men, with a
mean age of 64  17 years. There was no difference in age
between patients with recurrent or first-time DVT. Specific
patient characteristics are summarized in Table I.
Three parameters were evaluated in both groups of
patients: the location of DVT, the incidence of PE, and the
early clinical outcome at 4 weeks of follow-up.
The location of DVT
On the basis of the most proximal extent of the throm-
bus, the distribution of DVT was classified as follows: (1)
distal DVT involving veins distal to the popliteal vein
(CEAP anatomic classification, Ad 10, 11), and (2) proxi-
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mal DVT with involvement of the popliteal vein and more
proximal (CEAP anatomic classification, Ad 1-9).
The incidence of PE
The diagnosis of PE was established on the basis of
perfusion lung scans that routinely were obtained in all
patients who were treated for DVT. In doubtful cases, a
ventilation lung scan also was done. The diagnosis of PE
was made according to the criteria of the PIOPED study
investigators.16Lung scans were performed within 24
hours of admission.
Early (4-week) follow-up
All patients were followed for at least 4 weeks. All fatal
events during the period of hospitalization and the 4-week
follow-up interval were recorded, and autopsies were per-
formed after all in-hospital deaths. In addition, our data
include major bleeding complications and new symptom-
atic PE during anticoagulation therapy.
Treatment regimens
Patients received compression therapy and anticoagu-
lation therapy. All mobile patients remained mobile and
were encouraged to walk. None of the patients were treated
in an ambulatory fashion outside the hospital setting.
Compression therapy. Tight compression bandages
were applied to the affected leg up to the groin for at least
2 weeks or until swelling had subsided. The bandage was
changed every 3 days. The compression bandages used in
the lower leg were non-elastic zinc plaster (Varicex F,
Lohmann KG; Neuwied, Germany) wrapped with short-
stretch material (Rosidal K, Lohmann KG). Adhesive ban-
dages with Panelast (Lohmann KG) or Tricoplast (Beiers-
dorf AG, Hamburg, Germany) were applied on the thigh,
with considerable pressure over the knee up to the groin.
After 2 weeks, patients were prescribed class II compression
stockings (30-40 mm Hg).
Anticoagulation. All patients were treated with sub-
cutaneous low-molecular-weight heparin (Fragmin, Phar-
macia, Stockholm, Sweden) at a dose of 100 IU/kg body
weight, twice daily. The first dose was administered after
DVT had been diagnosed by duplex scanning. In the
absence of contraindications, oral anticoagulation with
coumarin (Marcoumar, Roche, Basle, Switzerland) was
initiated. The coumarin dose was adjusted to achieve and
maintain an international normalized ratio (INR) of 2.0 to
3.0. Low–molecular-weight heparin also was administered
in full doses until an INR of 2.0 to 3.0 was achieved. After
2 days with an INR of 2.0 to 3.0, low–molecular-weight
heparin was discontinued. In 39 patients, oral anticoagula-
tion was contraindicated because of an increased risk for
bleeding (eg, gastrointestinal ulceration) or injury (eg,
epilepsy), as well as for planned surgery. In these patients,
Fig 1. Distal deep vein thrombosis diagnosed by contrast phle-
bography.
Fig 2. Magnetic resonance imaging of an inferior vena caval
thrombosis.
Table I. Patient characteristics
First DVT Recurrent DVT Total
N (%) 631 (73) 233 (27) 864 (100)
Mean age  SD (y) 64  18 64  15 64  17
Gender
Male 263 (42) 136 (58) 399 (46)
Female 368 (58) 97 (42) 465 (54)
Data are n (%) of patients unless otherwise indicated.
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subcutaneous injection of low–molecular-weight heparin
was continued in a prophylactic dose (Fragmin, 5000 IU,
once daily).
Statistical analysis
Data are presented as mean values  SD when appro-
priate. Differences between two groups were tested for
statistical significance by 2 test and the Mann-Whitney U
test. The level of statistical significance was set at P  .05.
RESULTS
Extent of deep vein thrombosis. The incidence of
proximal DVT was significantly higher (P  .001) in pa-
tients with recurrent DVT than in patients with first DVT
(Table II). Of 233 patients with recurrent DVT, 210 (90%)
had a proximal DVT compared to only 79% of the patients
with first DVT. Conversely, the incidence of distal DVT
was significantly lower in patients with recurrent DVT
(10%) compared to patients with first DVT (21%).
Pulmonary embolism. Of the 864 patients enrolled
in this study, 859 received a perfusion or perfusion/venti-
lation lung scan to document the incidence of PE. No
ventilation/perfusion scans were performed for the remain-
ing five patients because of technical problems.
As indicated in Table II, the incidence of PE was
equally distributed between patients with recurrent DVT
and those with first DVT (P .05). Furthermore, there was
no statistically significant difference in the incidence of
symptomatic PE between patients with their first DVT and
those with recurrent DVT. It should be noted that none of
the patients with asymptomatic PE developed pulmonary
symptoms while receiving anticoagulative and compressive
therapy during the 4-week follow-up period.
Early (4-week) follow-up. A total of six patients died
(0.7%). Five were being treated for their first episode of
DVT, and four of these patients died of malignant disease.
One other 77-year-old patient in this group died as a
consequence of PE. One 88-year-old patient with proximal
recurrent DVT also died of malignant disease. No major
bleeding complications or new symptomatic PE occurred
during the 4-week follow-up interval.
DISCUSSION
The objective of the present study was to evaluate the
distribution of proximal and distal DVT in patients with
recurrent DVT compared to patients with first DVT. In
addition, we were interested in determining the incidence
of PE and the early outcome of anticoagulative and com-
pressive therapy in mobile patients with recurrent DVT. To
our knowledge, this is the first study in which the distribu-
tion of proximal and distal DVT has been compared be-
tween patients with first DVT and those with recurrent
DVT.
Our investigation has two principal findings. First, we
were able to document that patients with recurrent DVT
have a significantly higher incidence of proximal DVT. The
reason for the higher incidence of proximal DVT in patients
with recurrent DVT is not entirely clear. One hypothesis is
that postthrombotic changes and damage to venous valves
after a first clinical event might facilitate the extension of
DVT into proximal veins in patients who subsequently have
recurrent events. Another explanation could be that pa-
tients with recurrent DVT may be more likely to have
thrombotic risk factors and, therefore, are more likely to
develop extensive DVT.
The second principal finding in our study is that the
incidence of PE was nearly identical in patients with their
first DVT and in those with recurrent DVT. It is commonly
believed that patients with proximal DVT have a higher risk
of PE compared to patients with distal DVT,10-15 and for
this reason a higher incidence of PE might be expected in
patients with recurrent DVT. This clearly was not the case
in our series of patients, but the validity of this finding
should not be overestimated. Our data were collected
retrospectively at a single center, and a selection bias cannot
be completely excluded. Nevertheless, the high incidence
of proximal DVT among patients with recurrent DVT in
our study is similar to the results that have been reported by
Hansson et al.17
Statistical analysis was performed by G. Nirnberger,
PhD, Bioconsult, Vienna, Austria.
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